The latest research, guidelines, and FDA updates — summarized in plain English and updated daily.
Showing recent highlights
Researchers found that music-based therapies — things like moving or walking in time to a beat, or imagining movement while listening to music — may help people with multiple sclerosis (MS) walk better, covering more distance, moving more evenly, and at a steadier pace. This was the most consistent finding across 23 studies involving hundreds of people with MS. This is early research and hasn't yet changed treatment guidelines.
A study is looking at whether a program called iStep-MS — which encourages people with multiple sclerosis (MS) to move more and sit less throughout their day — can help reduce fatigue, one of the most exhausting and life-disrupting symptoms of MS. The program involves four personal sessions with a healthcare provider over three months, and researchers are testing it across a range of NHS and charity-funded care settings in England. This is early research and hasn't yet changed treatment guidelines.
Researchers found that more than half of people with mild-to-moderate multiple sclerosis (MS) — a condition where the immune system damages nerves, often affecting movement and balance — reported falling at least once over just three months, which can seriously affect their safety and independence. A study is looking at whether creating a personalized fall prevention plan with a physiotherapist, one tailored to each person's specific MS symptoms and daily habits, works better than giving everyone the same general fall-safety tips. This matters because falls are a major concern for people living with MS, and a more targeted approach could potentially help reduce them. This is early research and hasn't yet changed treatment guidelines.
Researchers found that a brain stimulation technique called tDCS — where a gentle electrical current is applied to the scalp through small electrodes — may help improve leg movement and balance in people with multiple sclerosis, with those receiving stronger stimulation for 20 minutes seeing the most benefit. Specifically, people showed improvements in how far they could walk and how steadily they could stand still, though walking speed and hand coordination didn't improve as much. This is early research and hasn't yet changed treatment guidelines.
Researchers found that taking natalizumab — a medication used for relapsing-remitting multiple sclerosis — less frequently (every 5 to 12 weeks instead of the usual every 4 weeks) did not significantly affect disability progression or the appearance of new lesions on brain scans for most measures. However, people on the less frequent schedule did show more active inflammation spots on a specific type of brain scan called gadolinium-enhancing lesions, which can signal ongoing disease activity. This is early research and hasn't yet changed treatment guidelines.
Researchers found that rituximab, an older and often less expensive medication used to treat relapsing multiple sclerosis, worked about as well as ocrelizumab (brand name Ocrevus) — a newer drug in the same family — at preventing new areas of damage showing up on brain scans over two years. Relapse rates and disability outcomes looked similar between the two groups, though infections were slightly more common with rituximab. This is early research and hasn't yet changed treatment guidelines.
Researchers found that people with multiple sclerosis (MS — a condition where the immune system mistakenly attacks the brain and spinal cord) who took high-dose vitamin D supplements over a long period were less likely to experience relapses (episodes where symptoms flare up) and showed small improvements in disability scores compared to those who took a placebo. The analysis looked at 32 studies involving more than 2,200 people with MS, and no major increase in serious safety concerns was found with vitamin D supplementation. This is early research and hasn't yet changed treatment guidelines.
Researchers found that combining virtual reality with treadmill walking may offer greater benefits for people with multiple sclerosis than treadmill walking alone — improving not just movement and balance, but also the ability to think and walk at the same time, which is a common challenge with MS. Participants also stayed motivated and stuck with the training well, which matters because keeping up with any exercise program can be tough when living with a chronic condition. This is early research and hasn't yet changed treatment guidelines.
A study found that people with multiple sclerosis who spent 12 weeks doing mentally engaging activities — things like puzzles, reading, or learning new skills — did not show measurable improvement on a standard thinking and processing test compared to those who did not. However, people who did not do those activities reported feeling like their mental abilities had gotten worse over that same period, suggesting that staying mentally active may help people feel more mentally sharp even if it doesn't show up clearly on formal tests. This is early research and hasn't yet changed treatment guidelines.
Researchers found that tiny molecules in the body called microRNAs — which help control how the immune system behaves — may explain why some people with multiple sclerosis respond well to a common MS treatment called interferon-beta, while others don't seem to benefit as much. By reviewing 13 studies, scientists identified more than 184 of these molecules that behaved differently in people who responded to the treatment compared to those who didn't, which could one day help doctors predict who will benefit from this therapy before they even start it. This is early research and hasn't yet changed treatment guidelines.
A study found that people with a mild form of multiple sclerosis (MS) — a disease where the immune system damages the nervous system — showed meaningful improvements in thinking skills, hand coordination, and the ability to use both hands together when they added 'Brain Gym' exercises to their regular physical therapy. Brain Gym involves movement-based activities thought to boost blood flow and brain chemistry. This is early research and hasn't yet changed treatment guidelines.
Researchers found that Sativex® — a cannabis-based mouth spray — helped reduce pain and muscle stiffness (called spasticity, where muscles feel tight or hard to control) in people with multiple sclerosis, based on a review of 20 studies. Spasticity affects up to 84% of people with MS and can make movement harder and pain worse, so finding treatments that address both is meaningful. This is early research and hasn't yet changed treatment guidelines.
Researchers found that a painless eye scan called OCT — which takes detailed pictures of the layers at the back of the eye — can reveal meaningful differences between people with multiple sclerosis (MS) and those with a related but distinct condition called neuromyelitis optica spectrum disorder (NMOSD). Specifically, people with NMOSD showed noticeably thinner nerve fiber layers in their eyes compared to people with MS, a difference that was especially striking in eyes that had already experienced optic neuritis (inflammation of the optic nerve that can cause vision loss). This matters because better tools for telling these two conditions apart could eventually help doctors make more accurate diagnoses and tailor treatment more precisely. This is early research and hasn't yet changed treatment guidelines.
Researchers found that a treatment called cladribine tablets helped reduce the rate of relapses — sudden worsening of symptoms — by 58% compared to no active treatment in people with a form of multiple sclerosis where the disease flares up and partially recovers. The study also found that cladribine tablets performed similarly to, or better than, many other MS medications when it came to slowing disease progression, meaning patients were less likely to experience a lasting decline in their abilities. This is early research and hasn't yet changed treatment guidelines.
Researchers found that people with progressive multiple sclerosis who made the most progress in specific attention-based computer training exercises — particularly ones focused on concentration and dividing attention between tasks — also showed the biggest improvements in how quickly their brain could process information. The study also found that people who started with better thinking skills, higher estimated intelligence, and older age tended to respond better to the training overall. This is early research and hasn't yet changed treatment guidelines.
Researchers found that when people with multiple sclerosis (MS) have trouble walking, it affects far more than just getting from place to place — it can make them feel disconnected from friends, family, and their community, and many of the biggest obstacles they face come from the outside world, like inaccessible buildings or unhelpful social environments, rather than from their illness alone. The study also found that the standard medical framework doctors and researchers use to understand disability may not fully capture what it actually feels like to live with walking difficulties caused by MS. This is early research and hasn't yet changed treatment guidelines.
Researchers found that people with multiple sclerosis tend to struggle more than healthy individuals with verbal fluency — that is, the ability to quickly think of and say words, like naming as many animals as possible in one minute. The same pattern was seen in people with a related condition called neuromyelitis optica spectrum disorder, and those with more advanced, progressive forms of multiple sclerosis showed the greatest difficulty. This matters because trouble with word-finding or quick thinking can affect daily life and work, and recognizing it as a real part of the condition may help patients and their doctors pay closer attention to cognitive (thinking and memory) health. This is early research and hasn't yet changed treatment guidelines.
Researchers found that adding short 'booster' exercise sessions every five weeks did not significantly help people with multiple sclerosis hold onto the physical gains they had made after completing a 12-week exercise program. Multiple sclerosis is a condition where the immune system affects the brain and nervous system, often making physical fitness harder to maintain. This is early research and hasn't yet changed treatment guidelines.
Researchers found that while people with multiple sclerosis respond very differently to ocrelizumab — a drug that reduces certain immune cells thought to drive MS — each individual person tends to follow a remarkably consistent personal pattern each time they receive a dose. In other words, if someone's immune cells take 40 weeks to bounce back after one dose, they're likely to take about the same amount of time after the next dose too, varying by only about 2 weeks on average. This matters because it could one day allow doctors to tailor dosing schedules to each patient's own biological rhythm rather than using a one-size-fits-all approach, potentially making treatment more convenient and personalized. This is early research and hasn't yet changed treatment guidelines.
A study found that people with progressive multiple sclerosis who did task-focused hand and arm exercises — with or without a virtual reality component — showed improvements in their ability to use their hands in daily life, and their brain scans showed increased activity in connected brain regions afterward. Interestingly, the more a person's hand function improved, the more their brain appeared to reorganize and adapt, suggesting the brain retains some flexibility even in progressive forms of the disease. This is early research and hasn't yet changed treatment guidelines.
Researchers found that people with multiple sclerosis who added either 'motor imagery' (mentally picturing themselves walking) or 'action observation' (watching others walk) to their regular rehabilitation sessions were able to walk noticeably farther — roughly 46 to 54 meters more in a six-minute walking test — compared to those who did standard rehabilitation alone. Both approaches also helped reduce fatigue, which is a common and challenging symptom for people living with MS. This is early research and hasn't yet changed treatment guidelines.
A study found that people with relapsing multiple sclerosis (a condition where the immune system attacks the nervous system, causing periodic flare-ups) who switched to ofatumumab — an injectable MS medication — after their previous oral medication stopped working well had very few new relapses and nearly no new areas of damage visible on brain scans. In fact, about 9 out of 10 participants showed no signs of disease activity at all during the study period. This is early research and hasn't yet changed treatment guidelines.
A study found that people with multiple sclerosis (MS) who wore special glasses that emit a bright, blue-toned light for just 20 minutes each morning reported feeling noticeably less fatigued — that deep, overwhelming tiredness that is one of the most common and difficult symptoms of MS — compared to a control group using dim red light glasses. The blue light glasses seemed to work faster and more strongly at reducing fatigue throughout the day, and participants also found them comfortable to use. This is early research and hasn't yet changed treatment guidelines.
Researchers are studying whether people with multiple sclerosis (MS) — a condition that affects the nervous system and can make movement difficult — might benefit from using a wearable robotic leg device at home every day for eight weeks. The goal is to see if this kind of technology could help improve their quality of life, reduce fatigue, and make walking easier compared to those who only received general advice about staying active. This is early research and hasn't yet changed treatment guidelines.
Researchers found that a protein measured in a simple blood test — called neurofilament light chain (NfL), which is released when nerve fibers are damaged — may help predict whether someone with multiple sclerosis (MS) is at higher risk for relapses or worsening disability, particularly in the most common form of MS called relapsing-remitting MS. People with elevated NfL levels in their blood were more than twice as likely to experience disease worsening compared to those with lower levels, suggesting this blood test could one day help doctors track how MS is progressing. This is early research and hasn't yet changed treatment guidelines.
Researchers found that listening to 'binaural beats' — a type of audio therapy where slightly different sound tones are played into each ear — was linked to lower stress hormone (cortisol) levels in people with multiple sclerosis (MS) after a stressful task. The study also found that people with MS showed a blunted stress response compared to healthy participants, meaning their bodies didn't react to stress the same way, which could affect their overall health and recovery. This is early research and hasn't yet changed treatment guidelines.
A study found that adults with multiple sclerosis (MS) — a condition where the immune system attacks the nervous system, often causing physical and emotional challenges — saw meaningful improvements in depression, anxiety, and daily functioning after completing an online therapy program based on Cognitive Behavioral Therapy (CBT), a well-known talk therapy approach that helps people manage difficult thoughts and feelings. Participants took six online lessons over 10 weeks and could check in with a psychologist by email or phone, with those improvements still holding up a full year later. This is early research and hasn't yet changed treatment guidelines.
Researchers found that people with multiple sclerosis (MS) who experience more depressive symptoms also tend to have poorer sleep quality, and vice versa — the two problems appear to go hand in hand. This connection was seen consistently across 21 studies involving more than 3,000 people with MS, suggesting that for people living with MS, struggles with mood and sleep may be closely linked rather than separate issues. This is early research and hasn't yet changed treatment guidelines.
Researchers found that people with multiple sclerosis generally felt positive about regularly filling out structured questionnaires — called patient-reported outcome measures — that track how they're feeling physically and emotionally. Patients said these check-ins made them feel more in control of their care and reassured them that their doctors were paying attention to their day-to-day experiences, not just test results. This is early research and hasn't yet changed treatment guidelines.
A study found that people with progressive multiple sclerosis (MS, a disease where the immune system attacks the nerves) safely completed a 12-week program of breathing lower-oxygen air — similar to being at high altitude — for a few hours several times a week, with no serious side effects. Researchers were testing whether this approach might help protect nerve cells in people with MS, and early results hinted at some possible improvements in disability-related measures. This is early research and hasn't yet changed treatment guidelines.